Notice 21 Apr 2025 compliance, healthcare, dea, legal, tennessee, drug enforcement, medicine

⚖️DEA Revokes Registration of Dr. John Stanton Due to Legal Issues

The Drug Enforcement Administration (DEA) issued an Order to Show Cause against Dr. John Stanton, proposing to revoke his registration due to the loss of state medical authority. The decision directly relates to his felony conviction and the revocation of his medical license in Tennessee, thereby blocking his ability to dispense controlled substances.

Learn More
Notice 18 Apr 2025 compliance, pharmaceuticals, clinical trials, dea, controlled substances, drug enforcement, myonex llc

💊Notice of Application for Controlled Substances by Myonex LLC

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 regulatory compliance, manufacturing, pharmaceutical industry, controlled substances, drug enforcement

💊Patheon API Services Inc. Applies for Controlled Substances Registration

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, united states, pharmaceuticals, manufacturing, controlled substances, drug enforcement, business registration

💊DEA Notice

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 regulatory compliance, pharmaceuticals, controlled substances, drug enforcement, bulk manufacturing, restek corporation

⚖️Restek Corporation's Bulk Manufacturer Application for Controlled Substances

Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 16 Apr 2025 regulatory compliance, healthcare, legal issues, licensing, federal programs, drug enforcement

⚖️DEA Denies Moustafa Aboshady's Registration Application

The Drug Enforcement Administration (DEA) issued an Order to Show Cause, proposing the denial of Dr. Moustafa M. Aboshady's DEA registration application. The basis for this denial stems from his mandatory exclusion from Medicare, Medicaid, and all Federal health care programs due to previous legal convictions related to false statements in healthcare benefits programs. The Agency concluded that substantial evidence supported the denial of his application for registration.

Learn More
Notice 16 Apr 2025 compliance, regulatory, pennsylvania, controlled substances, drug enforcement, pharmacy

💊DEA Revokes Registration of Empire and Skyline Pharmacies for Violations

The Drug Enforcement Administration issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy Inc. and Skyline Pharmacy Inc. for alleged violations concerning recordkeeping and dispensing of controlled substances. The order indicates potential revocation of their registration, deeming their operations inconsistent with public safety and legal standards.

Learn More
Notice 16 Apr 2025 compliance, healthcare, regulation, nevada, dea, drug enforcement, medical licensing

⚖️DEA Revocation of Registration

The Drug Enforcement Administration (DEA) revoked Ajumobi Agu, M.D.'s registration due to sustained illegal activity, including dispensing controlled substances without appropriate licenses. The order emphasizes the importance of compliance with both federal and state laws in the healthcare field, and the potential consequences for practitioners engaged in similar misconduct.

Learn More
Notice 16 Apr 2025 healthcare compliance, dea, florida, drug enforcement, registration revocation, medical regulations

⚖️DEA Revokes Registration of Victor Augusto Silva, M.D.

The Drug Enforcement Administration has revoked the registration of Dr. Victor Augusto Silva due to violations that allowed an unauthorized individual to prescribe controlled substances. This decision underscores the strict compliance required under federal and Florida laws regarding the use of DEA registrations and the serious implications of non-compliance for medical practitioners.

Learn More
Notice 14 Apr 2025 compliance, regulation, usa, legal, drug enforcement

📄Correction Notice from the U.S. Department of Justice – April 2025

The U.S. Department of Justice issued a clarification for "Decision and Order" concerning Phong H. Tran, M.D. The notice corrects a publication error in the Federal Register, explicitly specifying a date to replace placeholders in previously published information. This ensures accuracy in regulatory documentation.

Learn More